Related Experiment Video
Updated: May 4, 2026

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.6K
Breast cancer in the elderly-Should it be treated differently?
1Department of Oncology, 1st Faculty of Medicine and General University Hospital, U nemocnice 2, 128 08 Prague 2, Czech Republic.
Summary
Elderly breast cancer patients face poorer outcomes and delayed diagnosis. This review offers treatment recommendations for older adults, highlighting evidence gaps in clinical trials.
Area of Science:
- Geriatric Oncology
- Breast Cancer Research
Background:
- Breast cancer incidence rises with age, with a significant proportion diagnosed in women over 70.
- Elderly breast cancer patients exhibit poorer survival rates compared to younger counterparts.
- Delayed diagnosis and under-treatment contribute to adverse outcomes in older patients.
Purpose of the Study:
- To provide evidence-based recommendations for the management of breast cancer in the elderly.
- To address screening, surgical, and systemic treatment strategies for older breast cancer patients.
- To identify areas where further research is needed due to insufficient evidence in elderly populations.
Main Methods:
- Literature review focusing on breast cancer treatment in elderly patients.
- Analysis of current guidelines and clinical trial data, noting exclusions of older adults.
- Synthesis of information to formulate clinical recommendations.
Main Results:
- Specific recommendations are proposed for screening, surgery, radiotherapy, hormone therapy, and chemotherapy in elderly patients.
- The review highlights a general lack of robust evidence from large randomized trials for this demographic.
- Under-treatment and diagnostic delays are identified as key challenges.
Conclusions:
- Tailored treatment approaches are crucial for improving outcomes in elderly breast cancer patients.
- Further research, including dedicated trials for older adults, is essential to strengthen the evidence base.
- Addressing age-related factors in diagnosis and treatment is paramount.
Related Concept Videos
Drug Dosing: Geriatric Patients
395
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
395
Cancer Therapies
8.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
382
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
382
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Survival Analysis
863
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863
Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K

